Summit Therapeutics, Inc. (SMMT)
17.37
-0.28
(-1.59%)
USD |
NASDAQ |
Jan 15, 10:38
Summit Therapeutics Market Cap: 12.93B for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 34.59B |
| Madrigal Pharmaceuticals, Inc. | 11.49B |
| CorMedix, Inc. | 558.61M |
| Travere Therapeutics, Inc. | 2.560B |
| Viridian Therapeutics, Inc. | 3.165B |
Market Cap Related Metrics
| PEG Ratio | -0.0402 |
| Price to Book Value | 67.26 |
| Price | 17.37 |
| Earnings Yield | -7.15% |
| PEGY Ratio | -0.0402 |